← all drugs
Lamotrigine Tablet, Extended Release
being discontinued · Neurology · Snapshot: 2026-08-25
- Manufacturers listed
- Par Health, Inc.
- Machine-readable
- JSON for this drug
Presentations (6)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| Lamotrigine, Tablet, Extended Release, 100 mg (NDC 49884-563-11) | Par Health, Inc. | unknown | 04/29/2026 |
| Lamotrigine, Tablet, Extended Release, 25 mg (NDC 49884-561-11) | Par Health, Inc. | unknown | 04/29/2026 |
| Lamotrigine, Tablet, Extended Release, 50 mg (NDC 49884-562-11) | Par Health, Inc. | unknown | 04/29/2026 |
| Lamotrigine, Tablet, Extended Release, 300 mg (NDC 49884-605-11) | Par Health, Inc. | unknown | 04/29/2026 |
| Lamotrigine, Tablet, Extended Release, 200 mg (NDC 49884-564-11) | Par Health, Inc. | unknown | 04/29/2026 |
| Lamotrigine, Tablet, Extended Release, 250 mg (NDC 49884-604-11) | Par Health, Inc. | unknown | 04/29/2026 |
History
Daily change tracking began 2026-08-25 (index founding). Status flips and availability changes will accumulate here.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.